Nosocomial Fungal Infections in Target Population:A Prospective Survey

尹有宽,张继明,黄玉仙,石尧忠,翁心华

DOI: https://doi.org/10.3321/j.issn:1005-4529.2004.11.041

2004-01-01

Abstract:OBJECTIVE To investigate the risk factors, incidence and disease spectrum of nosocomial fungal infections. METHODS A prospective survey of nosocomial fungal infections was conducted on target patients hospitalized between Oct 1997-Dec 1999. Fifty six strains of Candida albicans isolated from patients with invasive fungal infections were tested for susceptibility to common antifungal agents. RESULTS The rates of nosocomial infections and nosocomial fungal infections were 12.30% and 2.57%, respectively. Nosocomial fungal infections occurred mainly in oral cavity (39.51%), lower respiratory tract (34.57%) and urinary tract (17.28%), the main pathogens of nosocomial fungal infections were Candida spp (90.62%). Developments of nosocomial fungal infections were closely associated with immunosuppressive therapy, endotracheal intubation or tracheotomy, coma (lasting more than 3 days), infusion of broad-spectrum antimicrobial agents (≥3 types of antimicrobial agents used simultaneously), malignancy and old age (≥65 years old). The rate of C. albicans susceptibility to amphotericin B, fluconazole, flucytosine (5-FC) and itraconazole were 100%, 94.6%, 92.86% and 57.1%, respectively. CONCLUSIONS The rate of nosocomial infections was higher in patients with immunosuppression, coma, indwelling catheters or receiving broad-spectrum antimicrobial agents therapy. Candida spp are still the main pathogens of nosocomial fungal infections. C. albicans has a high degree of susceptibility to amphotericin B, fluconazole and 5-FC and a lower degree of susceptibility to itraconazole.